Regulatory Compliance
5 articles on Regulatory Compliance, written by Shotlee and medically reviewed for clinical accuracy.
Illegal Peptide Shots in Brazil: The Hidden Risks for Expats
Foreign residents in Brazil face a growing grey market of unregulated injectable peptides. Here is what the health regulator Anvisa says about safety and legality.
7 min read
Driving on Ozempic & Mounjaro: Avoiding the £1,000 DVLA Fine
New regulations warn that GLP-1 medication users could face significant fines if side effects impair driving. Here is the complete guide to staying safe and compliant.
8 min read
MHRA Investigates UK Peptide Clinics Over Health Claims
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is probing peptide clinics for unlawful health claims on experimental therapies. A Guardian investigation uncovered websites touting benefits like tissue repair from BPC-157 despite scant human evidence. Clinics defend their practices amid rising interest in these injections.
5 min read
Celeb Agent: Why Stars Hide Ozempic, Wegovy Use
When celebrities drop dress sizes fast, whispers of 'fat jabs' like Ozempic fill the air—but stars stay mum. A veteran celeb agent exposes the regulatory pitfalls, contract traps, and multimillion-dollar reasons behind the secrecy. From TV bans to brand conflicts, here's why honesty could cost them dearly.
4 min read
Monster of 2025: GLP-1 Promotions
The year 2025 has seen a relentless barrage of ads promoting GLP-1 medications for weight loss, often bypassing FDA approvals and focusing on cosmetic benefits. Despite regulations limiting their use to specific medical conditions, telehealth companies push compounded versions aggressively. This trend threatens to undermine the body positivity movement by exploiting insecurities for profit.
5 min read